Considerations involving paramagnetic coordination compounds as useful NMR contrast agents.
Tweedle
M F
MF
Squibb Institute of Medical Research, New Brunswick, NJ 08903.
Gaughan
G T
GT
Hagan
J
J
Wedeking
P W
PW
Sibley
P
P
Wilson
L J
LJ
Lee
D W
DW
D000818:Animals; D002614:Chelating Agents; D003287:Contrast Media / Q000493:pharmacokinetics / Q000633:toxicity; D005682:Gadolinium / Q000493:pharmacokinetics; D006571:Heterocyclic Compounds; D008279:Magnetic Resonance Imaging; D051379:Mice; D009942:Organometallic Compounds / Q000493:pharmacokinetics / Q000633:toxicity
D002614:Chelating Agents; D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D005682:Gadolinium